Clinical Trials Directory

Trials / Conditions / HPV Infection

HPV Infection

119 registered clinical trials studyying HPV Infection42 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAssessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
NCT06210854
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
Not Yet RecruitingFeasibility of HPV Self-Collection Kits for Cervical Cancer Screening
NCT07453459
Washington University School of MedicineN/A
Not Yet RecruitingEvaluation of the Effect of a Dietary Supplement Based on EGCG, Vitamin B12, Hyaluronic Acid, and Folic Acid o
NCT07344337
Fondazione Policlinico Universitario Agostino Gemelli IRCCSN/A
RecruitingImplementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)
NCT07225530
Columbia UniversityN/A
RecruitingClinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
NCT07428330
UNC Lineberger Comprehensive Cancer CenterN/A
RecruitingImmunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
NCT07281677
Zhejiang Provincial Center for Disease Control and PreventionPhase 4
RecruitingEvaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NCT07281599
QurasenseN/A
RecruitingConcordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk
NCT06507917
Centre Hospitalier Universitaire de la RéunionN/A
RecruitingPopSci CHW4CervixHealth
NCT07336134
Thomas Jefferson UniversityN/A
Not Yet RecruitingA Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis
NCT06773819
Peking Union Medical College Hospital
Active Not RecruitingEarly Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV
NCT06959563
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairEARLY_Phase 1
Not Yet RecruitingRemote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program
NCT06921798
University of VirginiaN/A
RecruitingIdentification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Pre
NCT06522256
ANRS, Emerging Infectious DiseasesN/A
Not Yet RecruitingHospital-based Validation of the New ELEVATE Screening Tool
NCT06304610
University Hospital, GhentN/A
RecruitingTo Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Yea
NCT06756269
Shanghai Bovax Biotechnology Co., Ltd.Phase 2
Not Yet RecruitingEffector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure
NCT06681636
National Institute of Hygiene and Epidemiology, VietnamPhase 2
RecruitingFeasibility of HPV Testing With Mail-delivered Sample Collection Kits
NCT07087145
University of California, San Francisco
Not Yet RecruitingAll-cause and Diseases-specific Mortality of High-risk HPV Infection
NCT06631495
Peking Union Medical College Hospital
Enrolling By InvitationORCHID: An Online Intervention for Persons With HIV (Miami)
NCT05935644
University of MiamiN/A
Not Yet RecruitingHPV Infection and Vaginal Microecology in Immunosuppressed Women
NCT06619743
Lan Zhu
CompletedWhat is the Optimal Training Model for Cervical Awareness?
NCT06562595
Izmir City HospitalN/A
Active Not RecruitingA Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45
NCT06454175
Shanghai Bovax Biotechnology Co., Ltd.Phase 1
RecruitingCervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
NCT07202936
University of Bern
RecruitingAssessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
NCT06326294
Instituto Nacional de Saúde, MozambiqueN/A
Active Not RecruitingGame-Based Intervention to Promote HPV Vaccination
NCT06162676
Michigan State UniversityN/A
Active Not RecruitingVaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-
NCT06302725
Assistance Publique - Hôpitaux de ParisN/A
RecruitingHPV DNA Self-sampling in a General Practitioner's Office.
NCT06253169
Patient Organization Veronica
Active Not RecruitingHPV Self-testing in Transgender Individuals
NCT05883111
Queen Mary University of LondonN/A
RecruitingThe Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.
NCT06285357
Lo.Li.Pharma s.r.lN/A
RecruitingPocket Colposcopy Using CARE Algorithm
NCT06458062
Duke UniversityN/A
RecruitingNon-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT06291311
University Hospital Tuebingen
Not Yet RecruitingTwo Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity
NCT06137352
Fujian Maternity and Child Health Hospital
RecruitingPhase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions
NCT06075264
Frantz Viral Therapeutics, LLCPhase 2
UnknownPrevalence of ENT Diseseas
NCT06105346
Medical University of Graz
RecruitingGlobal Burden Estimation of Human Papillomavirus (GLOBE-HPV)
NCT06129253
International Vaccine Institute
Active Not RecruitingSELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
NCT06120205
Teal Health, Inc.N/A
RecruitingPCOM2 - The Physician Communication Intervention, Version 2.0
NCT05336240
University of Colorado, DenverN/A
CompletedInterferon Alpha Therapy for Cervical CINI and HPV Infection
NCT06137950
Mongolian National University of Medical SciencesPhase 1
RecruitingPhase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
NCT05829629
BlueSky Immunotherapies GmbHPhase 1
RecruitingComparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With
NCT06052033
First Affiliated Hospital of Wenzhou Medical UniversityN/A
CompletedThe Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief
NCT05990270
Kahramanmaras Sutcu Imam UniversityN/A
Active Not RecruitingA Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years
NCT06041061
Sinocelltech Ltd.Phase 3
Active Not RecruitingOptimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
NCT06002126
Weill Medical College of Cornell UniversityN/A
UnknownTreatment of HPV Infection in Perimenopausal and Postmenopausal Women
NCT05863975
Qianfoshan HospitalPhase 4
RecruitingPrevalence and Clinical Implications of HPV Infection in Male IBD Patients
NCT05911750
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Active Not RecruitingArtesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
NCT05555862
Frantz Viral Therapeutics, LLCPhase 2
CompletedClinical Correlation Between Self-collected and Physician-collected HPV Screening Kits
NCT05679141
Switch Health Solutions Inc.
Not Yet RecruitingIntegration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial
NCT05173324
International Agency for Research on CancerPhase 3
RecruitingComparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
NCT05672927
The University of Texas Medical Branch, GalvestonPhase 4
RecruitingDetermining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithel
NCT06574087
PCK Marine Hospital in GdyniaN/A
CompletedEfficacy of Lentinula Edodes-Derived Supplement (AHCC®) in Promoting Negativity of Persistent HPV Infection
NCT06752083
Liaquat University of Medical & Health Sciences
UnknownHuman Papillomavirus in Young People Epidemiological Research 3
NCT05587725
Monash University
UnknownHuman Papillomavirus in Young People Epidemiological Research 4
NCT05587738
Monash University
UnknownPrognostic Study of HPV Virus Integration in Women With HSIL
NCT05745597
Fujian Maternity and Child Health Hospital
UnknownELEVATE Acceptability Study
NCT06136702
University GhentN/A
CompletedThe SPOT-HPV Study
NCT05524025
Dana-Farber Cancer Institute
Completed1:1 Comparison of the Pocket Colposcope in Kenya
NCT04998318
Duke UniversityN/A
CompletedDEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk In
NCT05509413
Ruhr University of BochumN/A
CompletedClinic or Self-Sampling for Cervical Cancer Screening
NCT06177236
Istanbul University - CerrahpasaN/A
Active Not RecruitingValidation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)
NCT06452004
University Medical Center GroningenN/A
CompletedPrevention and Screening Towards Elimination of Cervical Cancer
NCT05234112
University Medical Center GroningenN/A
CompletedHPV Vaccine Immunity in High-risk Women
NCT04590521
Murdoch Childrens Research InstitutePhase 4
Active Not RecruitingAdding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania
NCT04953130
London School of Hygiene and Tropical MedicinePhase 4
WithdrawnImpact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS
NCT05341284
Peking University
Active Not RecruitingImmunogenicity of Fractional Dose of the HPV Vaccines
NCT05291871
University of WashingtonPhase 4
RecruitingA Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Ch
NCT05262010
National Vaccine and Serum Institute, ChinaPhase 3
RecruitingPsycho-emotional Impact of Preoperative Counselling in Cervico-carcinoma Screening Programs
NCT06500767
University of Turin, Italy
RecruitingEffect of HPV Integration on Prognosis of Young Women With CIN2 in China
NCT05282095
Fujian Maternity and Child Health Hospital
CompletedEffectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
NCT05435209
University of WashingtonPhase 4
CompletedIdentification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Te
NCT05340322
Duke UniversityN/A
UnknownAcceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65
NCT05414929
Université de SherbrookeN/A
CompletedHPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
NCT04982614
Columbia UniversityPhase 4
RecruitingThe Organ Transplant Recipient HPV and Skin Cancer Study
NCT05284877
Merete Haedersdal
UnknownClinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women
NCT05570331
Ding Ma
UnknownResearch About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
NCT05283239
Fujian Maternity and Child Health Hospital
TerminatedPrimary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments
NCT04278326
Centre Hospitalier Régional d'OrléansN/A
UnknownA Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL
NCT05282745
Fujian Maternity and Child Health Hospital
UnknownHPV Viral Load in Predicting the Prognosis of LSIL
NCT05051852
Fujian Maternity and Child Health Hospital
WithdrawnHPV Vaccine in Postpartum Women
NCT04430907
Milton S. Hershey Medical Center
Active Not RecruitingCharacteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection
NCT05003505
Fujian Maternity and Child Health Hospital
Unknown"Lactobacillus Crispatus M247, LSIL and Microbiota"
NCT05808816
Fondazione Policlinico Universitario Agostino Gemelli IRCCSPhase 4
RecruitingConcomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
NCT04910802
Miriam ElfströmPhase 4
CompletedLot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females
NCT04965350
Shanghai Zerun Biotechnology Co.,LtdPhase 3
CompletedBS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects
NCT04528407
BlueSky Immunotherapies GmbH
CompletedPrime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions
NCT04607850
Barinthus BiotherapeuticsPhase 1 / Phase 2
UnknownEvaluation of the Prevalence of Oral HPV Infection in Patients Who Are Positive to the PAP-test
NCT05949398
University of Catania
Active Not RecruitingNine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
NCT04255849
Weill Medical College of Cornell UniversityPhase 3
CompletedStudy of FluBHPVE6E7 in HPV-16 Infected Women
NCT04490512
BlueSky Immunotherapies GmbHPhase 1
CompletedHPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents
NCT04438291
Chinese University of Hong KongN/A
Active Not RecruitingAn Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination
NCT04206813
Boston Medical CenterPhase 4
CompletedSelf-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04679675
Kaiser PermanenteN/A
Active Not RecruitingIntradermal, Fractional Dose of HPV Vaccines:
NCT04235257
University of WashingtonPhase 4
RecruitingArtesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
NCT04098744
Frantz Viral Therapeutics, LLCPhase 2
UnknownNabothian Cyst Protects or Facilitates Against Cervical Cancer
NCT04488991
Haseki Training and Research Hospital
CompletedHPV-Based Screen-and-Treat Demonstration Project in Lilongwe
NCT04092257
UNC Lineberger Comprehensive Cancer CenterN/A
CompletedImmunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha
NCT04436133
National Vaccine and Serum Institute, ChinaPhase 2
UnknownHPV Prevalence in 16-20 Year Old Males
NCT04297670
Laval University
Active Not RecruitingImmunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women
NCT04270773
University Hospital Virgen de las NievesPhase 4
UnknownRetrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus
NCT04171505
Hospital San Carlos, Madrid
CompletedRe-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV
NCT04155294
University of Oxford
UnknownThe Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa"
NCT04794660
International Agency for Research on CancerPhase 3
CompletedThermocoagulation for Treatment of Precancerous Cervical Lesions
NCT04191967
University of California, San FranciscoN/A
CompletedA Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunog
NCT04083196
National Vaccine and Serum Institute, ChinaPhase 1
RecruitingTherapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (
NCT04057924
University Hospital, Bordeaux
UnknownHuman Papilloma Virus (HPV) Self-collection and Women Adherence
NCT05059015
Instituto Nacional de Cancerologia, ColumbiaN/A
CompletedClinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV
NCT04210336
Procare Health Iberia S.L.N/A
CompletedInvestigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by
NCT04199260
Procare Health Iberia S.L.
UnknownA Pilot Study on HPV and Cervical Cancer Screening in Mumbai
NCT03229603
Tata Memorial HospitalN/A
CompletedProbiotics Role in HPV Cervico-vaginal Infection Clearance
NCT05109533
Azienda Ospedaliero, Universitaria PisanaN/A
CompletedAntibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys
NCT04711265
Kenya Medical Research Institute
UnknownYallaferon in Chinese Population
NCT02593968
Lee's Pharmaceutical LimitedPhase 2
CompletedA New Supplement for the Immune Response to HPV Infection
NCT02263378
University of MessinaN/A
CompletedHPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine C
NCT04333212
Chang Gung Memorial HospitalN/A
CompletedEpidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cance
NCT02809352
CHU de Reims
CompletedHuman Papillomavirus Anal Infection
NCT02862795
Centre Hospitalier Universitaire de BesanconN/A
UnknownHuman Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men
NCT01300689
Chinese Academy of Medical Sciences
CompletedRecombinant Human Interferon a-2b Gel for HPV Gynecological Infections
NCT01824992
Lee's Pharmaceutical LimitedPhase 2 / Phase 3
CompletedHPV in Adolescents
NCT01788852
The HIV Netherlands Australia Thailand Research Collaboration
CompletedPolyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection
NCT01571141
AGUNCO Obstetrics and Gynecology CentrePhase 4